close

Enter

Log in using OpenID

Bioelectric Medicine Market Anlysis with Inputs from Industry Experts 2018 to 2026

embed
Bioelectric medicine is a new and innovative approach to diagnose and treat injuries and diseases. All major organs of the body are connected to the nerves, which allows the brain to monitor and regulate the functions of the organs.
Bioelectric Medicine Market Is Forecasted To
Witness A Thriving Growth By 2026
Bioelectric Medicine Market, By Product (Cardiac Pacemakers, Cochlear
Implants, Implantable Cardioverter Defibrillators, and Others), By Type
(Implantable Electroceutical Devices and Non-Invasive Electroceutical Devices),
By Application (Pain Management, Depression, Epilepsy, and Others), and By
Region - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Bioelectric medicine is a new and innovative approach to diagnose and treat injuries and diseases. All
major organs of the body are connected to the nerves, which allows the brain to monitor and regulate
the functions of the organs. Bioelectric medicine refers to the usage of a device to modulate and read
the electrical activity within the body’s nervous systems. Nerve blocking devices or nerve stimulating
devices that are held against the skin or implanted on a nerve have the potential to regulate specific
nerve activity, make specific changes in organ function, and also restore health, without much
complicated side effects of pharmaceutical agents. Click To Read More On Bioelectric Medicine
Market.
Bioelectric medicine technology is used to record, block, and stimulate neural signals to change the
way diseases and injuries are treated. It is also used for the treatment of conditions such as cancer,
paralysis, rheumatoid arthritis, and diabetes. Electroceuticals are alternatives to drug based remedies.
Bioelectric Medicine Market Drivers:
Mergers and acquisitions, advancements in technology, and innovations such as non-invasive devices
in the field of bioelectric medicines are the major factors driving growth of the bioelectric medicine
market. For instance, in 2016, GlaxoSmithKline Plc. (GSK) merged with Google’s parent company
Alphabet to set up a new bioelectric company called Galvani Bioelectronics, which will benefit over 2
billion people who are suffering from chronic diseases. GSK invested around US$ 615 million for the
development of Galvani Bioelectronics. In 2015, Synapse Electroceutical Technology, a UK-based
company launched a new product Accel-Heal, which is a non-invasive class 2A medical device. The
device also promotes healing of leg ulcers by using electrical energy. Accel-Heal delivers a sequence of
low level, pre-programmed and sub sensory electrical energy through surface of the skin.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1757
Synapse Electroceutical Technology has a product for venous leg ulcer management in the pipeline,
which is expected to fuel growth of the bioelectric medicine market over the forecast period. Other
factors that boost growth of the bioelectric medicine market include increasing number of diseases in
geriatric population such as cardiac arrhythmias, Parkinson’s disease, Alzheimer’s disease, epilepsy,
and depression, and rise in chronic diseases such as neurological and cardiac disorders.
Bioelectric Medicine Market Key Players:
Key players operating in the global bioelectric medicine market include Medtronic PLC, Sonava,
Boston Scientific Corporation, St Jude Medical, Liva Nova PLC, Biotronic, Second Sight Medical
Products, Nevro Corp, and Electrocare among others.
Bioelectric Medicine Market Regional Analysis:
Europe is expected to witness significant growth in the global bioelectric medicine market due to
mergers and acquisitions and advancements in R&D. For instance, in 2015, GSK had over 50 research
collaborations in the field of bioelectric medicine. In 2013, GSK invested in a start-up company called
Set Point, who is involved in the development of implantable devices that would stimulate the vagus
nerve in the neck with electrical impulses. North America is also expected to witness significant growth
in the bioelectric medicine market due to advancements in research and development.
For instance, Electro Core, a U.S.-based company is working on a device to treat headaches related to
migraines by stimulating vagus nerve on the neck with electrical impulses. In 2017, Reshape
Lifesciences launched minimally invasive medical devices ReShape Balloon, ReShape VBloc, and
ReShape Vest to treat obesity and metabolic diseases. In 2014, the U.S. FDA approved Inspire Medical
Systems’ Sleep Apnea Treatment to treat sleep apnea by implanting a device that stimulates air way
muscles. Asia Pacific is also expected to exhibit significant growth in the bioelectric medicine market,
owing to the rising number of people diagnosed with chronic diseases.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran303   documents Email
Document
Category
Health and Medicine
Views
1
File Size
367 KB
Tags
market
1/--pages
Report inappropriate content